COMPOSITION FOR PROPHYLAXIS OR TREATMENT OF IL-8 RELATED DISEASES

POLYPEPTIDE MODIFICATION METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS

MATERIALS AND METHODS FOR IMPROVED SINGLE CHAIN VARIABLE FRAGMENTS

ANTI-VEGF HEXAMERIC ANTIBODY AND COMPOSITION COMPRISING SAME

ANTI-TL1A ANTIBODIES AND METHODS OF USE THEREOF

Animal Models and Therapeutic Molecules

ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING MAGE-A

RADICALLY DIVERSE HUMAN ANTIBODY LIBRARY

HUMANIZED ANTIBODIES AND FRAGMENTS THEREOF BINDING TO CARBOHYDRATE ANTIGENS AND USES THEREOF

ANTI-TNFR2 ANTIBODY AND APPLICATION THEREOF

ANTI-CD47 MONOCLONAL ANTIBODY AND USE THEREOF

METHODS AND COMPOSITIONS RELATED TO BCL2 AND BIM HETERODIMER ANTIBODIES

Anti-ETEC adhesin protein antibodies and methods of use

SIRP-α binding proteins and methods of use thereof

AN ANTIBODY AGAINST P-CADHERIN AND USES THEREOF

Antibodies that target HIV GP120 and methods of use

ANTIBODIES SPECIFIC FOR QSOX1 AND METHODS OF USING THE SAME

ANTIBODIES AND METHODS OF USE

Type-II VNAR polypeptides which bind human TfR-1, encoding nucleic acids thereof and method of use thereof

GKN1 (GASTROKINE 1) SPECIFIC ANTIBODY, AND USE THEREOF

ANTI-SIRPalpha ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND USE THEREOF

BCMA-TARGETING SINGLE-DOMAIN ANTIBODY AND USE THEREOF

CD3 BINDING ANTIBODIES

ANTI-TSLP ANTIBODY PHARMACEUTICAL COMPOSITION AND USE THEREOF

ROR1-TARGETING ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

Anti-NGF antibodies and uses thereof

Methods and agents for the treatment of ocular disease

NOVEL CONJUGATE MOLECULES TARGETING CD39 AND TGFBETA

ANTIGEN-BINDING MOLECULES AND USES THEREOF

HUMANIZED CD19 ANTIBODY AND USE THEREOF

HUMANIZED MULTIVALENT PROTEIN CONJUGATES

SARS-COV-2 NUCLEOCAPSID ANTIBODIES

Antibody against Novel Coronavirus, and Reagent and Kit for Detecting Novel Coronavirus

MUTATIONS THAT DRIVE VH4 ANTIBODY AUTOREACTIVITY

CLEC9A antibodies

ANTI-IDIOTYPE COMPOSITIONS AND METHODS OF USE THEREOF

SINGLE-DOMAIN ANTIBODY TARGETING 4-1BB, FUSION PROTEIN THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF

Antigen binding molecules targeting SARS-CoV-2

CSPG4-TARGETING HUMANIZED CHIMERIC ANTIGEN RECEPTOR, IMMUNE EFFECTOR CELL EXPRESSING CHIMERIC ANTIGEN RECEPTOR, AND APPLICATIONS THEREOF

RATIONALLY DESIGNED, SYNTHETIC ANTIBODY LIBRARIES AND USES THEREFOR

SOLUBLE TCRS AND FUSIONS TO ANTI-CD3 RECOGNIZING KRAS G12D FOR THE TREATMENT OF CANCER

SINGLE DOMAIN ANTIBODIES BINDING TO SARS-COV-2 SPIKE PROTEIN

BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF

ANTI-CD5 ANTIBODY COMPOSITIONS AND USES THEREOF

DUAL CONJUGATION PROCESS FOR PREPARING ANTIBODY-DRUG CONJUGATES

NOVEL ANTIBODY LIBRARY PREPARATION METHOD AND LIBRARY PREPARED THEREBY

CD22 ANTIBODY AND APPLICATION THEREOF

ANTI-CD73 ANTIBODY AND USES THEREOF

SIGNAL PEPTIDE FOR REDUCING END HETEROGENEITY OF HETEROLOGOUS POLYPEPTIDE

MULTISPECIFIC ANTIBODIES FOR IMMUNO-ONCOLOGY

PD-L1 BINDING AGENTS AND USES THEREOF

MODIFIED ANTIBODY AND METHOD FOR MANUFACTURING SAME

Single Domain Antibodies and Their Use in Cancer Therapies

MUC1* ANTIBODIES

IL10RB binding molecules and encoding nucleic acids

IL27RAlpha binding molecules and methods of use

ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE

Interferon-gamma R2 (IFNGR2) binding molecules comprising single-domain antibodies and method of use thereof to treat autoimmune and inflammatory diseases

IL12 receptor synthetic cytokines and methods of use

HUMANIZED ANTI-IL-4Ra SINGLE DOMAIN ANTIBODY AND APPLICATION THEREOF

ANTIBODIES TO alpha-SYNUCLEIN AND USES THEREOF

MULTISPECIFIC ANTIBODY MOLECULES COMPRISINGLAMBDA AND KAPPA LIGHT CHAINS

IFNGR binding synthetic cytokines and methods of use

CD3 BINDING ANTIBODIES

HIV-1 ANTIBODIES

Animal Models and Therapeutic Molecules

METHOD FOR IMPROVING AFFINITY OF ANTIBODY FOR ANTIGEN AND USE THEREOF

METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING A DISEASE OR DISORDER ASSOCIATED WITH ABNORMAL LEVEL AND/OR ACTIVITY OF THE IFP35 FAMILY OF PROTEINS

Animal Models and Therapeutic Molecules

METHODS FOR DETECTING A TARGET IN A SAMPLE USING MUTATED NANOBODIES

COLLAGEN-TARGETED FUSION PROTEINS AND ANTIBODIES

SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN

Chimeric antigen receptors against multiple HLA-G isoforms

ANTIBODIES RECOGNIZING TAU

COMPOSITIONS COMPRISING ANTIBODIES TO HUMAN IDO-2

METHODS OF TREATING THYROID EYE DISEASE AND GRAVES' ORBITOPAHY USING INTERLEUKIN-17 (IL-17) ANTAGONISTS

ANTI-VWF ANTIBODIES AND USES THEREOF

Method for improving affinity of antibody for antigen and use thereof

Method for improving affinity of antibody for antigen and use thereof

POLYPEPTIDE MODIFICATION METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS

ANTIBODIES FOR BINDING PLASMIN

Chimeric Antigen Receptor (CAR) Comprising A CD19-Binding Domain

ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS

TREATMENT WITH ANTI-VEGF ANTIBODIES

COMPOSITIONS AND METHODS FOR ANTI-PACAP ANTIBODIES

NOVEL ANTIBODY FRAMEWORKS

METHOD FOR PRODUCING ANTIBODY

RECRUITING AGENT FURTHER BINDING AN MHC MOLECULE

ROR1-SPECIFIC ANTIGEN BINDING MOLECULES

ANG2-BINDING MOLECULES

Humanised anti-n-truncated amyloid β monoclonal antibody

ANTI-PD-L1 ANTIBODIES

Multispecific antibody comprising CD137 binding domain and PDL1 binding domain

CD19 BINDING MOLECULES AND USES THEREOF

NOVEL ANTI-CD3EPSILON ANTIBODIES

ENGINEERED CELL COMPOSITIONS AND METHODS OF USE THEREOF

Antibody and use thereof

Synthetic Single Domain Library

Method for improving affinity of antibody for antigen and use thereof

Transferrin receptor (TFR)-selective binding peptides capable of crossing the blood brain barrier, encoding nucleic acids thereof and methods of use thereof

ANTI-NR10 ANTIBODY AND USE THEREOF

ANTI-CD25 ANTIBODIES, ANTIGEN-BINDING FRAGMENTS THEREOF, AND MEDICAL USES THEREOF

ANTIBODIES TO CARBOHYDRATE ANTIGENS

Antibodies Binding to ILT4

Anti-CD-25 antibody

Conjugates of Biomolecule and Use Thereof

CHEMOKINE RECEPTOR 4 (CXCR4) ANTAGONIST ANTIBODIES

ANTI-PD-L1 ANTIBODY, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

ENGINEERED ANTIBODIES TO HIV ENV

CLDN18.2-TARGETING ANTIBODY, BISPECIFIC ANTIBODY AND USE THEREOF

ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME

Neutralizing anti-influenza binding molecules and uses thereof

FLAVIVIRUS CROSS NEUTRALIZING ANTIBODY AND PHARMACEUTICAL COMPOSITION

HUMAN CD47-TARGETING SINGLE-DOMAIN ANTIBODY AND USE THEREOF

CD3 BINDING ANTIBODIES

Antibodies to TGF-Beta

METHODS OF SEPARATING HOST CELL LIPASES FROM AN ANTI-LAG3 ANTIBODY PRODUCTION

ANTIBODIES AND ASSAYS FOR DETECTION OF BURKHOLDERIA MALLEI

ANTIBODY MOLECULES WHICH BIND CD22

CLAUDIN-6 BINDING MOLECULES AND USES THEREOF

Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor ligand (FLT3L) and uses thereof for treating autoimmune and inflammatory diseases

ANTI-TLR7 AGENTS AND COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME

Pertuzumab variants and evaluation thereof

BCMA-binding antibody and use thereof

EXPRESSION OF SEQUENCE-ENGINEERED LAMBDA ANTIBODY LIGHT CHAINS

Humanized anti-nuclear antibodies for targeting necrosis in cancer therapy

Nucleic acids encoding and methods of producing proteins comprising antibody chains

MATERIALS AND METHODS FOR POLYMERIC ANTIBODY RECEPTOR TARGETING

Sequence-Based High Throughput Method Generating Camelids Antibodies to Cover Broad Epitopes with High-Resolution

MEDITOPES AND MEDITOPE-BINDING ANTIBODIES AND USES THEREOF

COMPOSITIONS AND METHODS FOR DETECTING CELLS UNDERGOING FERROPTOSIS USING AN ANTIBODY

Methods for inhibiting tumor growth or treating cancer by administering an immunoglobulin single variable domain that binds glucocorticoid-induced TNFR family-related receptor (GITR)

ANTI-CANCER COMBINATION THERAPIES COMPRISING CTLA-4 AND PD-1 BLOCKING AGENTS

Humanized Antibodies That Recognize Alpha-Synuclein

Heterodimeric antibodies that bind CD3 and CD38

NOVEL ANTI-CD3 ANTIBODIES

POLYPEPTIDE MODIFICATION METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS

SINGLE DOMAIN ANTIBODIES SPECIFICALLY BINDING GLOBO - SERIES GLYCANS

Polypeptides comprising immunoglobulin chain variable domains which bind to interleukin-6 receptor (IL-6R) and methods of use thereof to treat autoimmune and inflammatory diseases

SERUM ALBUMIN BINDERS

ANTI-PD-L1 SINGLE-DOMAIN ANTIBODIES

ANTIBODIES AND METHODS OF USE

ANTI-8-HYDROXY-2'-DEOXYGUANOSINE ANTIBODY OR ANTIBODY FRAGMENT THEREOF, PRODUCTION METHOD, KIT, MEASURING METHOD, AND DEVICE FOR MEASUREMENT

ANTIBODIES RECOGNIZING TAU

NANO ANTIBODY FOR NEUTRALIZING TOXICITY OF SARS-COV-2 AND PREPARATION METHOD AND APPLICATION THEREOF

IL-23 and TNF-alpha binding bi-specific heavy chain polypeptides

IMMUNOGLOBULIN VARIABLE DOMAINS

IMMUNOGLOBULIN VARIABLE DOMAINS

ANTI-SIGLEC-8 ANTIBODIES AND METHODS OF USE THEREOF

ADAM9-Binding Molecules, and Methods of Use Thereof

GLYCOSYLATED IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

ANTIGEN-BINDING AGENTS THAT SPECIFICALLY BIND EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III

CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2

Anti-Siglec-5 antibodies and methods of use thereof

Anti P2X7 receptor antibodies and fragments thereof

Modified-IgG antibodies that bind transforming growth factor-BETA1 with high affinity, avidity and specificity

Heterodimeric antibodies that bind CD3 and GPC3

ANTI-HUMAN P40 PROTEIN DOMAIN ANTIBODY AND USE THEREOF

ANTI-CD40 ANTIBODIES AND USES THEREOF

FN14 antibodies and uses thereof

Anti-SIRPa antibodies and methods of use thereof

Cystic Fibrosis Transmembrane Conductance Regulator Stabilizing Agents

Chimeric antigen receptors against multiple HLA-G isoforms

ANTIBODIES AND BLOCKING THE INTERACTION OF VISTA AND ITS BINDING PARTNER

MODIFIED HUMAN VARIABLE DOMAINS

Antibody library and antibody screening method using same

Anti-myostatin antibodies and methods of use

ANTIBODIES RECOGNIZING TAU

Antibody compositions for disrupting biofilms

SOLUBLE MULTIMERIC IMMUNOGLOBULIN-SCAFFOLD BASED FUSION PROTEINS AND USES THEREOF

BINDING MEMBERS

ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF

TRISPECIFIC ANTIBODY TARGETING BCMA, GPRC5D, AND CD3

Method useful in tolerance induction therapy and kits therefore

Anti-B7-H4 antibodies and immunoconjugates

SUBSTANCE AND METHOD FOR TREATING TUMOR

Immunoglobulin variable domains

Antibodies to amyloid beta

Screening Methods and Assays for Use with Transmembrane Proteins, in Particular with GPCRs

ANTIBODY POLYPEPTIDES AND USES THEREOF

ANTI-GLYPICAN-3 ANTIBODIES AND USES THEREOF

POLYPEPTIDES

Humanized anti-A β monoclonal antibody and application thereof

Method for controlling affinity of antibody for antigen, antibody whose affinity for antigen has been altered, and its production method

HUMANIZED ANTIBODIES TO MUCIN-16 AND METHODS OF USE THEREOF

ANTIBODY WITH ENHANCED BINDING AFFINITY FOR ENDOTHELIN RECEPTOR TYPE A

ANTI-NOTCH3 ANTIBODY

NOVEL ANTI-HEPATITIS B VIRUS ANTIBODY AND USES THEREOF

Neutralizing antibodies to circumsporozoite protein and their use

Methods and agents for the treatment of ocular disease

METHOD FOR IMPROVING AFFINITY OF ANTIBODY FOR ANTIGEN AND USE THEREOF

T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS

ANTI-RHO GTPASE CONFORMATIONAL SINGLE DOMAIN ANTIBODIES AND USES THEREOF

Immunomodulatory antibodies

Method for improving affinity of antibody for antigen and use thereof

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR

Ha binding agents

ANTI-CD371 ANTIBODIES AND USES THEREOF

Anti-interleukin-6 receptor antibodies

Anti-complement C1s antibodies and uses thereof

ANTI-CLAUDIN 18.2 ANTIBODY AND APPLICATION THEREOF

RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN MICE

Method of preparing pH-dependent antibodies

Antibody molecules to dengue virus and uses thereof

NON-HUMAN ANIMALS HAVING AN IMMUNOGLOBULIN HEAVY CHAIN VARIABLE REGION THAT INCLUDES AN ENGINEERED DIVERSITY CLUSTER AND USES THEREOF

Methods of Engineering Surface Charge for Bispecific Antibody Production

ANTI-SIRPalpha MONOCLONAL ANTIBODIES AND USES THEREOF

HIV-1 gp120 CD4 binding site antibodies targeting HIV escape mutants

ANTI BDCA-2 ANTIBODIES

Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R)

Anti-MET antibodies and uses thereof

Anti-tumor necrosis factor (TNF) antibodies and compositions thereof

Anti-polymeric IgA antibodies and methods of use

ANTI-VISTA ANTIBODIES AND FRAGMENTS

Nucleic acid molecule encoding, and method of producing, a recombinant anti-tumor necrosis factor (TNF) antibody

Humanized anti-VEGF monoclonal antibody

Humanized anti-CCR7 receptor antibodies

CD47 antibodies and uses thereof for treating cancer

Humanized anti-VEGF antibody Fab fragment and use thereof

Immunoglobulin variable domains

IMMUNOGENETIC RESTRICTION ON ELICITATION OF ANTIBODIES

POLYPEPTIDE MODIFICATION METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS

A METHOD FOR THE TREATMENT OR PROPHYLAXIS OF CANCER BY TARGETING THE EXTRACELLULAR PORTION OF KERATIN 14 (KRT14) RESIDING ON CANCER CELLS

CDCP1-TARGETED THERAPIES

ANTI-PD-L1 ANTIBODIES AND USES THEREOF

CD3-SPECIFIC BINDING MOLECULES

Immunoglobulin variable domains

TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

Bispecific antibody specifically binding to IL-17A and TNF-α

10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their use

Antibodies recognizing tau

ANTIBODIES THAT TARGET HIV GP120 AND METHODS OF USE

CD133-BINDING AGENTS AND USES THEREOF

Antibodies comprising a polypeptide inserted in framework 3 region

ANTIBODIES AND METHODS OF USE

Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells

IL-7R-alpha SPECIFIC ANTIBODIES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA

ANTI-TIGIT ANTIBODIES AND METHODS OF USE

Anti-idiotypic antibodies against anti-GPRC5D antibodies

ANTI-CD39 ANTIBODIES

BAFF-R BISPECIFIC T-CELL ENGAGER ANTIBODY

Humanized and affinity matured antibodies to FcRH5 and methods of use

Anti-IL-6 antibody

Anti-CD38 antibodies and methods of use

CD73 BLOCKING ANTIBODIES

Combination Therapy for the Treatment of Cancer

Antibody that binds to VEGF and IL-1beta and methods of use

CD3 binding antibodies

Anti-ETEC adhesin protein antibodies and methods of use

RECOMBINANT ANTIBODY OF ANTI-HUMAN N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE

Humanized anti-CD79B antibodies and immunoconjugates and methods of use

Bispecific binding molecules binding to VEGF and Ang2

CD47 ANTIBODY, PREPARATION METHOD THEREFOR AND USES THEREOF

NEW ANTI TAU SVQIVYKPV EPITOPE SINGLE DOMAIN ANTIBODY

Anti-kit antibodies and uses thereof

Humanized anti-PD-1 antibody and the use thereof

LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereof

METHOD FOR IMPROVING INHIBITION OF VEGF-BINDING TO VEGF-R1 OF AN ANTI-VEGF ANTIBODY

ANTI-TAQ DNA POLYMERASE ANTIBODY AND USE THEREOF

Transferrin receptor (TfR)-selective binding peptides capable of crossing the blood brain barrier and methods of use thereof

Anti-c-Met antibody showing enhanced stability or antigen-binding fragments thereof

Chimeric antigen receptors against multiple HLA-G isoforms

Anti-podoplanin antibody

Anti-VLA-4 antibodies

Antigen-binding constructs targeting HER2

TFR-SPECIFIC BINDING MOIETIES AND TRANSCYTOSIS METHOD TO SELECT VNARS THAT CROSS CELLULAR BARRIERS

Anti-Siglec-5 antibodies and methods of use thereof

HUMANIZED MONOCLONAL ANTIBODIES AGAINST INTERLEUKIN-6, ENCODING GENES AND USES THEREOF

NS1-binding protein

Anti-CD39 antibodies

METHOD FOR MASS HUMANIZATION OF NON-HUMAN ANTIBODIES

Anti-PD-L1 antibodies

Anti-transthyretin antibodies

ANTI-ABETA ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF AND APPLICATION THEREOF

T CELL RECRUITING POLYPEPTIDES BASED ON CD3 REACTIVITY

NON-HUMAN ANIMALS THAT SELECT FOR LIGHT CHAIN VARIABLE REGIONS THAT BIND ANTIGEN

Anti-OX40 antibody, antigen-binding fragment thereof, and the pharmaceutical use

Antibodies that bind transforming growth factor beta (TGF beta) and methods of use thereof for treatment

Anti-tenascin C antibodies and uses thereof

VACCINE AND ANTIBODY AGAINST CLOSTRIDIOIDES DIFFICILE TOXIN

NOVEL ANTI-SIRPA ANTIBODIES

ANTI-KLRG1 ANTIBODIES

BLYS ANTIBODY, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

METHODS AND COMPOSITIONS FOR TREATING TAUOPATHIES

HUMANISED ANTI-N-TRUNCATED AMYLOID BETA MONOCLONAL ANTIBODY

TRANSGENIC PLANT COMPRISING A POLYNUCLEOTIDE ENCODING A VARIABLE DOMAIN OF HEAVY-CHAIN ANTIBODY

Humanized antibodies with increased stability

METHODS FOR TREATING OCULAR DISEASES

Monoclonal antigen-binding proteins to intracellular oncogene products

Single domain binding molecule

ANTIBODY FRAMEWORKS FOR REDUCING AGGREGATION OF MULTISPECIFIC ANTIBODIES

HEAVY CHAIN ONLY ANTIBODIES TO ANG-2

Monoclonal antibodies against Ambra-1

Binding protein of NS1 protein

IMMUNOMODULATORY ANTIBODIES

Antagonistic anti-tumor necrosis factor receptor superfamily antibodies

BI-SPECIFIC BINDING MOLECULES

Polypeptides

MICE EXPRESSING A LIMITED IMMUNOGLOBULIN LIGHT CHAIN REPERTOIRE

Single-domain antibody binding to the G protein alpha